Dentsply Sirona (XRAY) said Tuesday it is planning to refocus its Byte business model and is assessing the go-to-market business and economic model.
The company said that in connection with the review, it won't reinstate the at-home Byte Aligner Systems and Impression Kits but will still support non-contraindicated Byte Aligner patients currently undergoing treatment.
Dentsply Sirona said it will continue to work with regulators and get any needed clearances before any market launch.
In October 2024, the company voluntarily suspended sales and marketing of its Byte Aligners and Impression Kits while it reviewed certain regulatory requirements related to the products.
Price: 18.75, Change: +0.09, Percent Change: +0.48
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.